BioVentrix

BioVentrix is a privately held medical device company based in San Ramon, California. The company has 25 employees and reported $6.4 million in revenue. BioVentrix is dedicated to advancing treatment options for congestive heart failure (CHF) stemming from ischemic cardiomyopathy. The company develops less invasive, catheter-based approaches to treat CHF, aiming to improve patient outcomes and quality of life. BioVentrix's solutions are designed to benefit patients by offering a less invasive treatment that addresses the root cause of heart failure. This approach also provides advantages for payers by reducing hospitalizations and mitigating the need for more costly procedures like transplants or left ventricular assist devices (LVADs). Furthermore, BioVentrix's innovative solutions enable healthcare providers to become leaders in heart failure treatment, offering cutting-edge care to patients dealing with this increasingly prevalent and costly disease. For more information, please visit BioVentrix's website at bioventrix.com.